Search
60 Degrees Pharmaceuticals Inc
SXTPAdd to Watchlist
1.710USD
-0.040-2.29%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.75MMarket Cap
LossP/E TTM
More Details of 60 Degrees Pharmaceuticals Inc Company
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is used for malaria prevention in individuals 18 years and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.
60 Degrees Pharmaceuticals Inc Info
Ticker SymbolSXTP
Company name60 Degrees Pharmaceuticals Inc
IPO dateJul 12, 2023
CEODow (Geoffrey S)
Number of employees3
Security typeOrdinary Share
Fiscal year-endJul 12
Address1025 Connecticut Avenue Nw
CityWASHINGTON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code20036
Phone12023275422
Websitehttps://60degreespharma.com/
Ticker SymbolSXTP
IPO dateJul 12, 2023
CEODow (Geoffrey S)
Company Executives of 60 Degrees Pharmaceuticals Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
24.13K
+30.46%
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
3.95K
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
1.32K
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
1.14K
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
59.00
--
Dr. Stephen Toovey
Dr. Stephen Toovey
Independent Director
Independent Director
59.00
--
Mr. Paul Field
Mr. Paul Field
Independent Director
Independent Director
59.00
--
Mr. Patrick Gaynes
Mr. Patrick Gaynes
Investor Relations Officer
Investor Relations Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
24.13K
+30.46%
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
3.95K
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
1.32K
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
1.14K
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
59.00
--
Dr. Stephen Toovey
Dr. Stephen Toovey
Independent Director
Independent Director
59.00
--
FAQs
Who are the top five shareholders of 60 Degrees Pharmaceuticals Inc?
The top five shareholders of 60 Degrees Pharmaceuticals Inc are: Dr. Geoffrey S. Dow, Ph.D.
How many institutions hold shares of 60 Degrees Pharmaceuticals Inc (SXTP)?
As of 2026Q1, 27 institutions hold shares of 60 Degrees Pharmaceuticals Inc, with a combined market value of approximately 228.38K, accounting for 8.66% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 141573.00.